High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>

We observed a case of high-risk neuroblastoma (NB) carried by a 28-month-old girl, displaying metastatic disease and a rapid decline of clinical conditions. By array-CGH analysis of the tumor tissue and of the metastatic bone marrow aspirate cells, we found a high-grade amplification of six regions...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marzia Ognibene, Loredana Amoroso, Fraia Melchionda, Davide Cangelosi, Federico Zara, Stefano Parodi, Annalisa Pezzolo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/24fd725f332c4ac48cb27bee6e26080b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:24fd725f332c4ac48cb27bee6e26080b
record_format dspace
spelling oai:doaj.org-article:24fd725f332c4ac48cb27bee6e26080b2021-11-25T17:03:59ZHigh Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>10.3390/cancers132257922072-6694https://doaj.org/article/24fd725f332c4ac48cb27bee6e26080b2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5792https://doaj.org/toc/2072-6694We observed a case of high-risk neuroblastoma (NB) carried by a 28-month-old girl, displaying metastatic disease and a rapid decline of clinical conditions. By array-CGH analysis of the tumor tissue and of the metastatic bone marrow aspirate cells, we found a high-grade amplification of six regions besides <i>MYCN</i> on bands 2p25.3–p24.3. The genes involved in these amplifications were <i>MYT1L</i>, <i>TSSC1</i>, <i>CMPK2, RSAD2</i>, <i>RNF144A</i><i>, GREB1</i>, <i>NTSR2</i>, <i>LPIN1</i>, <i>NBAS,</i> and the two intergenic non-protein coding RNAs <i>LOC730811</i> and <i>LOC339788</i>. We investigated if these DNA co-amplifications may have an effect on enhancing tumor aggressiveness. We evaluated the association between the high expression of the amplified genes and NB patient’s outcome using the integration of gene expression data of 786 NB samples profiled with different public platforms from patients with at least five-year follow-up. NB patients with high expression of the <i>TSSC1</i> gene were associated with a reduced survival rate. Immunofluorescence staining on primary tumor tissues confirmed that the TSSC1 protein expression was high in the relapsed or dead stage 4 cases, but it was generally low in NB patients in complete remission. <i>TSSC1</i> appears as a putative new oncogene in NB.Marzia OgnibeneLoredana AmorosoFraia MelchiondaDavide CangelosiFederico ZaraStefano ParodiAnnalisa PezzoloMDPI AGarticleneuroblastomagenomic amplification<i>TSSC1</i>gene expressionsurvivalNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5792, p 5792 (2021)
institution DOAJ
collection DOAJ
language EN
topic neuroblastoma
genomic amplification
<i>TSSC1</i>
gene expression
survival
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle neuroblastoma
genomic amplification
<i>TSSC1</i>
gene expression
survival
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Marzia Ognibene
Loredana Amoroso
Fraia Melchionda
Davide Cangelosi
Federico Zara
Stefano Parodi
Annalisa Pezzolo
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>
description We observed a case of high-risk neuroblastoma (NB) carried by a 28-month-old girl, displaying metastatic disease and a rapid decline of clinical conditions. By array-CGH analysis of the tumor tissue and of the metastatic bone marrow aspirate cells, we found a high-grade amplification of six regions besides <i>MYCN</i> on bands 2p25.3–p24.3. The genes involved in these amplifications were <i>MYT1L</i>, <i>TSSC1</i>, <i>CMPK2, RSAD2</i>, <i>RNF144A</i><i>, GREB1</i>, <i>NTSR2</i>, <i>LPIN1</i>, <i>NBAS,</i> and the two intergenic non-protein coding RNAs <i>LOC730811</i> and <i>LOC339788</i>. We investigated if these DNA co-amplifications may have an effect on enhancing tumor aggressiveness. We evaluated the association between the high expression of the amplified genes and NB patient’s outcome using the integration of gene expression data of 786 NB samples profiled with different public platforms from patients with at least five-year follow-up. NB patients with high expression of the <i>TSSC1</i> gene were associated with a reduced survival rate. Immunofluorescence staining on primary tumor tissues confirmed that the TSSC1 protein expression was high in the relapsed or dead stage 4 cases, but it was generally low in NB patients in complete remission. <i>TSSC1</i> appears as a putative new oncogene in NB.
format article
author Marzia Ognibene
Loredana Amoroso
Fraia Melchionda
Davide Cangelosi
Federico Zara
Stefano Parodi
Annalisa Pezzolo
author_facet Marzia Ognibene
Loredana Amoroso
Fraia Melchionda
Davide Cangelosi
Federico Zara
Stefano Parodi
Annalisa Pezzolo
author_sort Marzia Ognibene
title High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>
title_short High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>
title_full High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>
title_fullStr High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>
title_full_unstemmed High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene <i>TSSC1</i>
title_sort high grade of amplification of six regions on chromosome 2p in a neuroblastoma patient with very poor outcome: the putative new oncogene <i>tssc1</i>
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/24fd725f332c4ac48cb27bee6e26080b
work_keys_str_mv AT marziaognibene highgradeofamplificationofsixregionsonchromosome2pinaneuroblastomapatientwithverypooroutcometheputativenewoncogeneitssc1i
AT loredanaamoroso highgradeofamplificationofsixregionsonchromosome2pinaneuroblastomapatientwithverypooroutcometheputativenewoncogeneitssc1i
AT fraiamelchionda highgradeofamplificationofsixregionsonchromosome2pinaneuroblastomapatientwithverypooroutcometheputativenewoncogeneitssc1i
AT davidecangelosi highgradeofamplificationofsixregionsonchromosome2pinaneuroblastomapatientwithverypooroutcometheputativenewoncogeneitssc1i
AT federicozara highgradeofamplificationofsixregionsonchromosome2pinaneuroblastomapatientwithverypooroutcometheputativenewoncogeneitssc1i
AT stefanoparodi highgradeofamplificationofsixregionsonchromosome2pinaneuroblastomapatientwithverypooroutcometheputativenewoncogeneitssc1i
AT annalisapezzolo highgradeofamplificationofsixregionsonchromosome2pinaneuroblastomapatientwithverypooroutcometheputativenewoncogeneitssc1i
_version_ 1718412764230189056